{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-102321","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2026-09-23T00:18:52+00:00","discovered_at":"2026-09-23T10:05:06.649382+00:00","generated_at":"2026-09-23T10:05:45.777503+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apimeds completes 1-for-10 reverse stock split; share count falls to 1.51M","bullets":["Reverse stock split effective 12:01 a.m. ET on July 24, 2026; every 10 shares combined into 1 share.","Shares outstanding reduced from 15,091,180 to 1,509,118; 33,506 additional shares issued for fractional rounding.","Par value reduced from $0.01 to $0.001 per share; authorized shares unchanged at 100M common, 10M preferred.","Common stock trades on NYSE American under 'APUS' on split-adjusted basis; new CUSIP 03771D201.","Proportionate adjustments made to outstanding equity awards and warrants and their exercise prices."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-102321","json":"https://secwatch.observer/filing/0001213900-26-102321.json","markdown":"https://secwatch.observer/filing/0001213900-26-102321.md","text":"https://secwatch.observer/filing/0001213900-26-102321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026102321/0001213900-26-102321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026102321/ea0306326-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T10:05:45.777503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}